Breakthrough in ovarian cancer: Selumetinib
Friday, February 15, 2013 - 21:00
in Health & Medicine
Researchers have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.